Novavax, Inc. (NASDAQ: NVAX) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it will be featured in a coming presentation, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The presentation news; what we’re seeing from NVAX stock … Read more
Novavax, Inc. (NASDAQ: NVAX) is down a bit in the market this morning, leaving some investors wondering if this is a signal to sell or a discount in the making. In my opinion, this is an opportunity in the making. Today, we’ll talk about: Why I believe that NVAX stock is an opportunity; what we’re … Read more
Novavax, Inc. (NASDAQ: NVAX) is having a strong day in the market today. However, if you go digging for press releases or SEC filings, you’re not going to find any. Nonetheless, there is a very good reason for the gains. Today, we’ll talk about: Why NVAX stock is making a run for the top; what … Read more
Novavax, Inc. (NASDAQ: NVAX) is having a relatively strong start to the trading session in the market this morning, and a much needed one. The stock is working to recover from the more than 66% decline experienced yesterday as the result of a failed trial. Nonetheless, the stock is on a rebound this morning as … Read more
Novavax, Inc. (NASDAQ: NVAX) is having a horrible start to the trading session this morning, and for good reason. The company provided results from a Phase 3 trial that missed the mark, upsetting investors and sending the stock tumbling. Today, we’ll talk about: The data; what we’re seeing from NVAX stock as a result; and … Read more
Novavax, Inc. (NASDAQ: NVAX) is tumbling in the market this morning with no real news that has been released as the catalyst. After scouring message boards, we found several investors saying that this was a discount in the making, but is it? What’s coming up that makes them believe that? Today, we’ll talk about: Whether … Read more
Novavax, Inc. (NASDAQ: NVAX) is edging up in the market this morning, and for good reason. The company announced leadership promotions. While the excitement seems to be tappered thanks to the bloodshed in the market yesterday, the stock is seeing small gains early on in the pre-market. Today, we’ll talk about: The management update; what … Read more
Novavax, Inc. (NASDAQ: NVAX) is having a great start to the trading session this morning, and for good reason. The company was the center of an analyst upgrade, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: The upgrade; what we’re seeing from NVAX stock as a result; and what … Read more
Novavax, Inc. (NASDAQ: NVAX) is headed up early on in the market this morning, and for good reason. The comapny announced the initiation of a Phase 2 clinical trial, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The trial initiation; what we’re seeing from NVAX as a … Read more
Novavax, Inc. (NASDAQ: NVAX) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that a peer reviewed journal has published data surrounding the company’s flagship clinical candidate. Of course, the news proved to be positive, leading to excitement among investors and sending the stock upward. … Read more